Usage
Outcomes achieved using a digital service model for COPD
RECEIVER participants self-reported on their condition at least once per week for the majority of follow up.
Let's look at what that means when considering how Lenus can transform the traditional COPD pathway.
Evidence stats
How the Lenus Service has demonstrated sustained use
-
4
Average daily PRO sets per week in RECEIVER
-
77%
RECEIVER participants completed 1+ PRO set per week over majority of follow-up
Chart supplement
More information on the data visualised
| n | 83 (at baseline) |
|---|---|
| Inclusion Criteria | RECEIVER cohort criteria |
| Weekly Interaction Criteria |
Number of weekly interactions was determined by the number of daily CAT entries completed each week through the patient application. Service interaction levels were calculated relative to the number of service users who were alive and onboarded long enough to complete entries at each timepoint. |
- Number of weekly interactions were defined by the number of daily COPD assessment test (CAT) entries that were completed each week.
- The percentage of service users with each level of interaction was calculated at each timepoint from the service users who were alive and onboarded long enough to complete entries during that week.
Study details
ClinicalTrials.gov Identifier: NCT04240353
The feasibility and service adoption observational cohort RECEIVER trial was commenced in September 2019 by NHS Greater Glasgow and Clyde to evaluate the implementation and efficacy of the Lenus COPD Service with high-risk COPD participants matched 1:5 to a control cohort using de-identified contemporary routine clinical data. The protocol is published here with the full results available here.
| Control | RECEIVER | |||
|---|---|---|---|---|
| Inclusion Criteria |
Selected from the NHS Greater Glasgow and Clyde Safe Haven COPD dataset. Control cohort identification was conducted by iteratively identifying the individuals in the cohort who met the matching criteria for each RECEIVER participant. Duplicate control patients or individuals subsequently onboarded to Lenus COPD were excluded and then the optimal 5 matches for each RECEIVER participant were determined based on closest matches by age. The matching criteria were that matched individuals must: be alive at the onboarding date of the RECEIVER participant, be the same sex as the RECEIVER participant, and have had a COPD or respiratory related admission in the 7 days prior to the RECEIVER participant's onboarding date. |
At least one severe COPD exacerbation in the year prior to onboarding to Lenus COPD and/or chronic hypercapnic respiratory failure/sleep disordered breathing requiring NIV/CPAP treatment. | ||
| 1st Participant Index Date | 3rd September 2019 | |||
| Censor Date | 31st August 2021 | |||
| Total Patients | 415 | 83 | ||
NICE advice
Medtech Innovation Briefing
The National Institute of Health and Care Excellence (NICE) has developed a medtech innovation briefing (MIB) on Lenus COPD Support Service for remotely managing chronic obstructive pulmonary disease available here.
Meet our experts
Get in touch if you would like to meet with our product or sales specialists. We'll be pleased to provide solution demonstrations and discuss pricing.
We are a Crown Commercial Service Supplier. Our solutions are on UK frameworks: G-Cloud 13, Spark DPS and AI DPS.
